Homogeneous remifentanil-propofol blend for patient controlled a

Details Homogeneous remifentanil-propofol blend for patient controlled a Homogeneous remifentanil-propofol blend for patient controlled a

1999-12-03

2000-06-06

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514731, A61K 31445, A61K 3105

Patent

active

060719338

ABSTRACT:
The present invention utilizes a homogeneous mixture of Propofol (2,6-diisopropylphenol) and Remifentanil (N-Phenyl-N-(4-piperidinyl) amides), designed to deliver a constant proportion of drugs to the patient, specifically designed to provide enhanced results when administered via a PCA modality. The Remifentanil/Propofol homogeneous mixture (REMIPRO) is supplied in a dosage range of 1,000 parts Propofol to 10 parts Remifentanil (1,000 microgram Propofol: 10 microgram Remifentanil) to 20,000 parts Propofol to 10 parts Remifentanil (20,000 microgram Propofol: 10 ug Remifentanil). Induction of anesthesia via REMIPRO provides increased patient and physician satisfaction, increased safety, and decreased overall cost as the patient will be more alert after the procedure and will leave the hospital faster.

REFERENCES:
patent: 5637625 (1997-06-01), Haynes
patent: 5866591 (1999-02-01), Gatlin et al.
patent: 5908869 (1999-06-01), Jones et al.

Affiliated with

Also associated with

Rating

Homogeneous remifentanil-propofol blend for patient controlled a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Homogeneous remifentanil-propofol blend for patient controlled a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homogeneous remifentanil-propofol blend for patient controlled a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2213933